1. Targeting the USP7/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC/LSD1 inhibitors
   Letizia Granieri et al, 2022, Cell Reports CrossRef
2. Recent advances in the role of Yes‐associated protein in dermatosis
   Xiaorong Jia et al, 2023, Skin Research and Technology CrossRef
3. USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy
   Zhou-rui Ma et al, 2023, International Immunopharmacology CrossRef
4. ADAM9 deubiquitination induced by USP22 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition of trophoblast cells in preeclampsia
   Jie Liu et al, 2024, Placenta CrossRef
5. ATXN3 promotes prostate cancer progression by stabilizing YAP
   Longxiang Wu et al, 2023, Cell Communication and Signaling CrossRef
6. Identification of substrates for human deubiquitinating enzymes (DUBs): An up-to-date review and a case study for neurodevelopmental disorders
   Nagore Elu et al, 2022, Seminars in Cell & Developmental Biology CrossRef
7. RNAi-Based Screening for the Identification of Specific Substrate-Deubiquitinase Pairs
   Nagore Elu et al, 2023, The Ubiquitin Code CrossRef
8. Protein degradation: expanding the toolbox to restrain cancer drug resistance
   Hui Ming et al, 2023, Journal of Hematology & Oncology CrossRef
9. Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis
   Mickael Ohanna et al, 2022, Cancers CrossRef